Pediatric OTC Cough/Cold Rulemaking Absent From FDA Regulatory Agenda
This article was originally published in The Tan Sheet
Executive Summary
The Spring 2015 unified agenda lists June for a final rule on deeming electronic cigarettes and other alternatives to traditional cigarettes and smokeless tobacco products subject to FDA regulation. FDA adds an item to create a single set of regulations on fixed-combination Rx and OTC drugs.
You may also be interested in...
Draft Guidance Drills Down With Details To Cut Pediatric Acetaminophen Overdose Risk
FDA suggests new and repeats previous recommendations to reduce the risk of pediatric overdose with acetaminophen products due either to unsupervised ingestion or therapeutic errors. The guidance includes greater detail on delivery devices and labeling information for pediatric acetaminophen OTCs.
Industry News Roundup
Extended water-resistant sunscreen claims sought; clock starts on food facility registrations; U.K. loosens pediatric ADR guidance; FTC warns firms in ‘Operation Full Disclosure’ initiative; lice-prevention hair care brands beware; FDA warns West Coast Labs of adulterated supplements; and Mannatech expands in Singapore.
OTC Benzocaine Needs Label Warning, Indication Change – Public Citizen
In a citizen petition the group asks FDA to remove teething for children 2 years and older as an indication for some benzocaine products and require a label warning for OTC monograph benzocaine products concerning the risk of methemoglobinemia.